Genelux GNLX
NASDAQ GNLX
$2.72 -0.02 (-0.73%)
As of: Aug 21, 2026 · 2:03 PM EDT

Genelux (GNLX) EBITDA Margin (2022 - 2024)

Genelux (GNLX) posted quarterly EBITDA Margin of 101437.5% for Q1 2024, down 9763632.0% year-over-year from N/an in Q2 2023, and down 2568.58% quarter-over-quarter from 3801.18% in Q1 2023.

Genelux (GNLX) EBITDA Margin (2022 - 2024) Analysis & Trends

Genelux's EBITDA Margin history runs 3 years deep, the most recent figure standing at 101437.5% for Q1 2024.

  • In Q1 2024, EBITDA Margin fell 9763632.0% year-over-year to 101437.5%; the TTM figure through Dec 2024 stood at 396200.0% (down 38198529.0% YoY), while the FY2025 annual figure was 415175.0%, down 1897500.0% from the prior year.
  • EBITDA Margin for Q1 2024 stood at 101437.5%, down from 3801.18% in the prior quarter.
  • The five-year high for EBITDA Margin was 57.67% in Q3 2022, with the low at 101437.5% in Q1 2024.
  • The 3-year median for EBITDA Margin is 1886.3% (2022), against an average of 26288.11%.
  • Peak annual rise in EBITDA Margin reached 9763632 bps in 2024, while the deepest fall reached 9763632 bps in 2024.
  • Genelux's EBITDA Margin stood at 28.57% in 2022, then sank by 13405 bps to 3801.18% in 2023, then slumped by 2569 bps to 101437.5% in 2024.
  • Business Quant data shows GNLX's EBITDA Margin at 101437.5% in Q1 2024, 3801.18% in Q1 2023, and 28.57% in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Vertex Pharmaceuticals 139.24 Bn 131.39 Bn 2.84 Bn 37.40%
2 Regeneron Pharmaceuticals 86.01 Bn 78.02 Bn 3.93 Bn 30.15%
3 Argenx Se 65.61 Bn 60.42 Bn 1.37 Bn 32.54%
4 Moderna 56.92 Bn 51.78 Bn 52.00 Mn -562.07%
5 BeOne Medicines 42.17 Bn 37.07 Bn 1.53 Bn 19.06%
6 Alnylam Pharmaceuticals 31.58 Bn 28.27 Bn 992.69 Mn 17.93%
7 BioNTech SE 27.77 Bn 9.38 Bn 668.28 Mn -35.57%
8 Insmed 27.52 Bn 26.36 Bn 358.27 Mn -0.36%
9 Royalty Pharma 27.36 Bn 26.52 Bn - 19.75%
10 Genelux 120.09 Mn 120.09 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2024 -101,437.50%
Mar 31, 2023 -3,801.18%
Dec 31, 2022 28.57%
Sep 30, 2022 57.67%